The US Academy of Sciences has withdrawn a published article concerning the 'cure' for pancreatic cancer. This decision was made after discovering that the lead author and co-authors held financial interests in the company developing the therapies.

La academia decidió retirar ese artículo al comprobar que Mariano Barbacid y dos de las coautoras del trabajo, tienen intereses financieros en Vega Oncotargets, que se creó con el objetivo de desarrollar terapias contra este tipo de cáncer